Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/04/16 → 31/12/22 |
Funding
- National Institute for Health Research: £1,465,255.84
GEM3: A multi-centre double-blind placebo-controlled randomised trial of a combination of methotrexate and gefitinib versus methotrexate alone as a treatment for ectopic pregnancy
- Horne, Andrew (Principal Investigator)
- Duncan, Colin (Co-investigator)